Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
NRXS
Strong SellSinkerNeurAxis, Inc. · Healthcare · United States · $75M · Avg Vol: $471K/d
18
StockRankGet insider-trade alerts
Q
34
V
22
M
44
P/E (TTM)
—
ROE
-139.8%
D/E
0.0x
Dividend %
—
COMPANY DESCRIPTION
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.7M | 2.5M | 2.7M | 3.6M | 10.0% | 5.3M | 8.3M | 20.7M | 140.8% |
| EPS | -0.44 | -2.25 | -1.22 | -0.95 | — | -0.76 | -0.76 | -0.27 | — |
| Shares | 12.5M | 6.5M | 7.0M | 10.7M | -14.6% | 12.6M | — | — | — |
| Debt | 0.6M | 0.2M | 0.5M | 0.4M | -11.4% | 0.3M | — | — | — |
| Equity | -5.6M | -1.4M | 2.1M | 3.4M | 64.4% | — | — | — | — |
| Op CF | -2.3M | -6.7M | -6.1M | -6.4M | — | -5.6M | — | — | — |
| Inv CF | -61.2K | -71.8K | -27.8K | -0.1M | — | — | — | — | — |
| Fin CF | 2.3M | 6.6M | 9.7M | 7.8M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-9.4%
SMA 50SMA 200
Close
$5.69
RSI (14)
26.6
52W High
$9.33
From 52W High
0.6%
SCORE BREAKDOWN
Quality
34
ROIC
-198.9%2.8
ROE
-139.8%6.4
GP/Assets
71.0%94.7
Op. Margin
-110.2%16.4
FCF/Assets
-102.5%2.0
Piotroski
431.0
Int. Cover
-50.0x5.9
D/E Ratio
0.04x73.1
Current Ratio
3.04x55.8
Value
22
P/E (TTM)
—N/A
EV/EBITDA
-8.8x25.0
P/FCF
—N/A
P/B
11.0x10.7
P/S
14.1x20.7
Div Yield
—N/A
Momentum
44
52W High %
61%38.2
RS 6M
-24%35.5
SMA 50/200
1.09x73.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+64%62.8
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$75M
P/E (Forward)
-22.1x
Gross Margin
85.6%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NRXS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| NRXS | NeurAxis, Inc.(you) | $75M | 18 | Strong Sell |
| LONA | LeonaBio, Inc. | $75M | 18 | Strong Sell |
| 4875.T | MediciNova, Inc. | $70M | 18 | Strong Sell |
| OSTX | OS Therapies Incorporated | $76M | 15 | Strong Sell |
| PMVP | PMV Pharmaceuticals, Inc. | $65M | 19 | Strong Sell |
| TELO | Telomir Pharmaceuticals, Inc. | $78M | 13 | Strong Sell |
| ACET | Adicet Bio, Inc. | $85M | 23 | Sell |
| ANVS | Annovis Bio, Inc. | $73M | 12 | Strong Sell |
| IMA | ImageneBio, Inc. | $61M | 15 | Strong Sell |
| HYFT | MindWalk Holdings Corp. | $65M | 14 | Strong Sell |
Peer medians: ROE -30.2% · P/E 27.0x · Gross margin 58.1%